FDA Approved: MERCAPTOPURINE — Supplemental Application (Nova Laboratories, Ltd)

View source ↗

Summary

The FDA approved a supplemental application for mercaptopurine (Purixan) by Nova Laboratories, Ltd., updating the product labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Purixan (Mercaptopurine)

Snippet

SUPPL AP for MERCAPTOPURINE (MERCAPTOPURINE)